Swiss Life iFunds (CH) Bond Global Corporates (CHF hedged) I-A 2

Reference Data

ISIN CH0219870703
Valor Number 21987070
Bloomberg Global ID BBG005H797G2
Fund Name Swiss Life iFunds (CH) Bond Global Corporates (CHF hedged) I-A 2
Fund Provider Swiss Life Asset Management AG Zürich, Switzerland
Phone: +41 44 284 77 09
E-Mail: info@swisslife-am.com
Web: www.swisslife-am.com
Fund Provider Swiss Life Asset Management AG
Representative in Switzerland
Distributor(s) Swiss Life AG
Zürich
Phone: +41 43 284 33 11
Asset Class Bonds
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** Investment funds under Swiss law in the category "Other funds for traditional investments" - Investments in foreign currency debt securities of companies, including agencies and supranationals - A maximum of 10% government debt securities can also be included - Active bond selection, duration management and yield curve positioning - Debtor limitation: 10% (exception: if min. 8.3% representation in the benchmark, max. 120% of the benchmark weighting) - Average rating: at least BBB - Foreign currency risks will be at least 90% hedged against Swiss franc
Peculiarities

Fund Prices

Current Price * 795.02 CHF 30.06.2025
Previous Price * 792.97 CHF 27.06.2025
52 Week High * 810.60 CHF 16.09.2024
52 Week Low * 774.49 CHF 11.04.2025
NAV * 795.02 CHF 30.06.2025
Issue Price * 796.93 CHF 30.06.2025
Redemption Price * 796.93 CHF 30.06.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 686,783,071
Unit/Share Assets *** 77,533,464
Trading Information SIX

Performance

YTD Performance +1.21% 31.12.2024
30.06.2025
1 month +0.97% 30.05.2025
30.06.2025
3 months +0.46% 31.03.2025
30.06.2025
6 months +1.07% 30.12.2024
30.06.2025
1 year +2.40% 01.07.2024
30.06.2025
2 years +3.96% 30.06.2023
30.06.2025
3 years +0.74% 30.06.2022
30.06.2025
5 years -11.88% 30.06.2020
30.06.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

GlaxoSmithKline Capital Inc. 4.875% 1.00%
PacifiCorp. 7.375% 0.93%
Erste & Steiermarkische Bank Dionicko Drustvo 0.75% 0.80%
Dell International L.L.C. and EMC Corporation 5.5% 0.75%
DnB Bank ASA 5.896% 0.72%
NatWest Group PLC 3.723% 0.71%
American Medical Systems Europe B.V. 3% 0.71%
JPMorgan Chase & Co. 5.294% 0.70%
AES Corp. 5.8% 0.70%
JPMorgan Chase & Co. 5.13518% 0.68%
Last data update 31.03.2025

Cost / Risk

TER 0.53%
TER date 30.09.2020
Performance Fee ***
PTR
Max. Management Fee *** 0.65%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)